Skip to content

Elysa Jill Marco, M.D.

NPI 1518032713ActiveIndividual· Pediatrics, Neurodevelopmental Disabilities· San Francisco, CA

Pediatrics, Neurodevelopmental Disabilities (M.D.) in San Francisco, California, licensed in CA, with an NPI issued in November 2006. Part D covered 167 prescriptions written in 2024, 89% of them generic. Sage Therapeutics, LLC was the largest of 2 companies reporting payments in 2025, $4,787 in all, mostly consulting fees.

Overview

NPI1518032713
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedNov 22, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Neurodevelopmental Disabilities Primary2080P0008XA78152CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Neurology (CA)

Part D prescriptions in 2024

Prescriptions (claims)167 · 228 30-day fills
Total drug cost$22,031
Generic share89% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$4,787 · 3 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Sage Therapeutics, LLC$4,7502
Astellas Pharma US Inc$37.221

What the 2025 payments were for

  • Consulting Fee$4,750 · 2 payments
  • Food and Beverage$37.22 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Neurodevelopmental Disabilities providers in San Francisco

All Pediatrics, Neurodevelopmental Disabilities providers in California